GLP1R and cirrhosis of liver: Moreover, Simon et al. demonstrated that the incidence of esophageal variceal hemorrhage was significantly lower in the SGLT2i group or GLP-1 receptor agonist group compared to that in the DPP4i and sulfonylurea groups in patients with T2DM and liver cirrhosis [40].